Potassium Ion

Potassium Ion

SCHEMBL4296985

CC1=Nc2ccc3cc(S(=O)(=O)[O-])ccc3c2C1(C)C.[K+]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
THRB P10828 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTPN1 P18031 2/20 0.33
IDO1 P14902 1/20 0.32
CASP6 P55212 2/20 0.32
FGF1 P05230 1/20 0.31
CYP2C9 P11712 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL30084855 1.00 MEN1 (0.55) MEN1KMT2ATHRBTDP1LMNA
SCHEMBL9815017 0.97 MEN1 (0.55) MEN1KMT2ATHRBTDP1LMNA
SCHEMBL4296859 0.88 MEN1 (0.56) MEN1KMT2ATHRBTDP1LMNA
SCHEMBL9815014 0.86 MEN1 (0.55) MEN1KMT2ATHRBTDP1LMNA
SCHEMBL4021394 0.86 MEN1 (0.55) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL28948590 0.86 MEN1 (0.55) MEN1KMT2ATHRBTDP1LMNA
Potassium Ion SCHEMBL14695214 0.82 MEN1 (0.43) MEN1KMT2ATDP1LMNA
SCHEMBL18031555 0.78 MEN1 (0.66) MEN1KMT2ATHRBTDP1LMNA
SCHEMBL1369158 0.78 DUSP5 (0.42) MEN1KMT2ATHRBTDP1LMNA
SCHEMBL101283 0.78 KMT2A (0.57) MEN1KMT2ATHRBTDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11866588-B2 Polymerizable near-IR dyes PROFUSA, INC. (US) 2024-01-09 US disclosed
US-20210040326-A1 AZACYANINE DYES AND USE THEREOF ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2021-02-11 US disclosed
EP-3768780-A1 AZACYANINE DYES AND USE THEREOF ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2021-01-27 EP disclosed
US-20200140690-A1 POLYMERIZABLE NEAR-IR DYES PROFUSA, INC. (US) 2020-05-07 US disclosed
US-10633542-B2 Azacyanine dyes and use thereof Ecole polytechnique fédérale de Lausanne (EPFL) (CH) 2020-04-28 US disclosed
US-20190292371-A1 AZACYANINE DYES AND USE THEREOF INTRACE MEDICAL SA (CH) 2019-09-26 US disclosed
WO-2019180475-A1 AZACYANINE DYES AND USE THEREOF ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2019-09-26 WO disclosed
US-20180079906-A1 AZACYANINE DYES AND USE THEREOF Ecole polytechnique fédérale de Lausanne (EPFL) (CH) 2018-03-22 US disclosed
US-8071388-B2 Compositions and methods for biodetection by nucleic acid-templated chemistry ENSEMBLE THERAPEUTICS CORPORATION (US) 2011-12-06 US disclosed
US-20090275142-A1 COMPOSITIONS AND METHODS FOR BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY ENSEMBLE THERAPEUTICS CORPORATION 2009-11-05 US disclosed
EP-2066813-A2 COMPOSITIONS AND METHODS FOR BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY Ensemble Discovery Corporation (US) 2009-06-10 EP disclosed
WO-2008054600-A2 COMPOSITIONS AND METHODS FOR BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY ENSEMBLE DISCOVERY CORPORATION (US) 2008-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275142-A1 COMPOSITIONS AND METHODS FOR BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY POLRMT, NT5C3B, RNGTT MEN1 1957/4885KMT2A 3161/4885THRB 4465/4885
US-20210040326-A1 AZACYANINE DYES AND USE THEREOF INMT, AZI2, MYADM MEN1 541/4885KMT2A 574/4885THRB 2983/4885
US-20190292371-A1 AZACYANINE DYES AND USE THEREOF INMT, AZI2, MYADM MEN1 541/4885KMT2A 574/4885THRB 2983/4885
US-10633542-B2 Azacyanine dyes and use thereof INMT, AZI2, MYADM MEN1 541/4885KMT2A 574/4885THRB 2983/4885
US-20180079906-A1 AZACYANINE DYES AND USE THEREOF INMT, AZI2, MYADM MEN1 541/4885KMT2A 574/4885THRB 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.